| 1 | Autistic Children/Adolescents Have Lower Adherence to the Mediterranean Diet and Higher Salivary IL-6 Concentration: Potential Diet–Inflammation Links? | 2.6 | 4 | Citations (PDF) |
| 2 | Circadian Disruption and Mental Health: The Chronotherapeutic Potential of Microbiome-Based and Dietary Strategies | 4.5 | 41 | Citations (PDF) |
| 3 | Structure and Functioning of Acute Inpatient Psychiatric Units in Spain: Qualitative Study | 1.2 | 0 | Citations (PDF) |
| 4 | Subgroups of Children with Autism Spectrum Disorder without Intellectual Disability: A Longitudinal Examination of Executive and Socio-Adaptive Behaviors in Adolescence | 2.6 | 8 | Citations (PDF) |
| 5 | Developmental outcomes in adolescence of children with autism spectrum disorder without intellectual disability: A systematic review of prospective studies | 7.5 | 10 | Citations (PDF) |
| 6 | Empirical examination of executive functioning, ADHD associated behaviors, and functional impairments in adults with persistent ADHD, remittent ADHD, and without ADHD | 3.3 | 41 | Citations (PDF) |
| 7 | Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study | 1.6 | 26 | Citations (PDF) |
| 8 | Large expert-curated database for benchmarking document similarity detection in biomedical literature search | 3.0 | 21 | Citations (PDF) |
| 9 | Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 14.8 | 906 | Citations (PDF) |
| 10 | Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 | 14.8 | 822 | Citations (PDF) |
| 11 | Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 14.8 | 2,751 | Citations (PDF) |
| 12 | Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment | 1.4 | 25 | Citations (PDF) |
| 13 | Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 | 14.8 | 622 | Citations (PDF) |
| 14 | Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 | 14.8 | 1,568 | Citations (PDF) |
| 15 | Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes | 3.0 | 32 | Citations (PDF) |
| 16 | Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 14.8 | 667 | Citations (PDF) |
| 17 | Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 14.8 | 1,813 | Citations (PDF) |
| 18 | Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 14.8 | 4,175 | Citations (PDF) |
| 19 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 14.8 | 6,821 | Citations (PDF) |
| 20 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 14.8 | 2,143 | Citations (PDF) |
| 21 | Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 | 14.8 | 313 | Citations (PDF) |
| 22 | Hepatitis C Crónica y usuarios con un historial de inyección de drogas en España: evaluación de la población, retos para un tratamiento efectivo. | 0.9 | 11 | Citations (PDF) |
| 23 | Nonmedical use of prescription drugs in the European Union | 3.3 | 154 | Citations (PDF) |
| 24 | Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 14.8 | 1,850 | Citations (PDF) |
| 25 | Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 14.8 | 5,635 | Citations (PDF) |
| 26 | Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 14.8 | 6,137 | Citations (PDF) |
| 27 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 14.8 | 4,701 | Citations (PDF) |
| 28 | Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 14.8 | 658 | Citations (PDF) |
| 29 | Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 | 14.8 | 478 | Citations (PDF) |
| 30 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 | 4.8 | 499 | Citations (PDF) |
| 31 | Clinical guideline for the treatment of dual pathology in the adult population | 0.9 | 8 | Citations (PDF) |
| 32 | Novel psychoactive substance use in the European Union | 3.1 | 0 | Citations (PDF) |
| 33 | Who says this is a modern disorder? The early history of attention deficit hyperactivity disorder | 3.1 | 25 | Citations (PDF) |
| 34 | Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder | 2.5 | 13 | Citations (PDF) |
| 35 | Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions | 1.8 | 54 | Citations (PDF) |
| 36 | Editorial | 0.9 | 10 | Citations (PDF) |
| 37 | Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder | 1.6 | 0 | Citations (PDF) |
| 38 | Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition | 1.8 | 31 | Citations (PDF) |
| 39 | Rethinking Dual Disorders/Pathology | 0.5 | 40 | Citations (PDF) |
| 40 | Addressing Dual Diagnosis Patients Suffering from Attention-Deficit Hyperactivity Disorders and Comorbid Substance Use Disorders | 0.5 | 11 | Citations (PDF) |
| 41 | Nutritional Education of Secondary Education Students and Diet Quality 2013, , 207-218 | | 0 | Citations (PDF) |
| 42 | Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain | 2.9 | 5 | Citations (PDF) |
| 43 | Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder | 6.8 | 115 | Citations (PDF) |
| 44 | PMH16 Budgetary Impact Analysis of Buprenorphine/Naloxone (Suboxone®) in Opioid Maintenance Treatment in Spain | 0.2 | 0 | Citations (PDF) |
| 45 | Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies | 2.8 | 47 | Citations (PDF) |
| 46 | Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile | 2.7 | 28 | Citations (PDF) |
| 47 | UNPLANNED VERSUS PLANNED DISCHARGES FROM IN-PATIENT ALCOHOL DETOXIFICATION: RETROSPECTIVE ANALYSIS OF 470 FIRST-EPISODE ADMISSIONS | 1.9 | 70 | Citations (PDF) |
| 48 | Patient or client, what substance misuse attenders want to be called, who they want to be treated with, where they want to be seen | 0.3 | 0 | Citations (PDF) |
| 49 | What Makes Alcohol-Dependent Individuals Early in Abstinence Crave for Alcohol: Exposure to the Drink, Images of Drinking, or Remembrance of Drinks Past? | 3.0 | 25 | Citations (PDF) |
| 50 | Gender differences in cocaine dependent patients: a 6 month follow-up study | 3.1 | 113 | Citations (PDF) |
